HiJAKing Immunotherapy-Resistant Melanoma for a Cure.

Lewis Zhichang ShiHongxing ShenOluwagbemiga A OjoJames A Bonner

Published in: The oncologist (2023)

Immune checkpoint blockers (ICBs) have brought great promise to patients with advanced melanoma, a tumor type that was claimed largely incurable not long ago. However, therapeutic resistance to ICBs has limited their utility in the clinic. Here, we provide a commentary on recent research endeavors concerning ICB resistance in melanoma patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
skin cancer
chronic kidney disease
prognostic factors
primary care
basal cell carcinoma
machine learning
angiotensin converting enzyme
patient reported outcomes
patient reported
artificial intelligence
deep learning